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Introduction: Obstructive Sleep Apnea and Hypopnea Syndrome (OSAS) is a highly prevalent disease with serious conse-
quences for the patients’ lives. The treatment of the condition is mandatory for the improvement of the quality of life, as well as 
the life expectancy of the affected individuals. The most frequent treatments provided by dentistry are mandibular advancement 
devices (MAD) and orthognathic surgery with maxillomandibular advancement (MMA). This is possibly the only treatment 
option which offers high probability of cure. Objective: The present article provides a narrative review of OSAS from the 
perspective of 25 years of OSAS treatment clinical experience.Conclusion: MADs are a solid treatment option for primary 
snoring and mild or moderate OSAS. Patients with severe apnea who are non-adherent to CPAP may also be treated with 
MADs. Maxillomandibular advancement surgery is a safe and very effective treatment option to OSAS.
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Introdução: a Síndrome da Apneia e Hipopneia Obstrutiva do Sono (SAOS) é uma doença muito prevalente e que 
traz importantes consequências para a vida dos seus portadores. O tratamento da condição é relevante para a melhora do 
bem-estar geral e da expectativa de vida dos afetados. Os tratamentos odontológicos mais frequentes para a SAOS são os 
dispositivos de avanço mandibular (DAMs) e a cirurgia ortognática de avanço maxilomandibular (AMM) — essa última, 
possivelmente, é a única opção de tratamento com alta probabilidade de cura do problema. Objetivo: o presente artigo 
faz uma revisão narrativa da SAOS sob a perspectiva de 25 anos de experiência clínica no tratamento da doença. Conclu-
são: os DAMs são uma sólida opção de tratamento para o ronco primário e apneias leves ou moderadas. Apneias graves, 
em pacientes que não se adaptam ou se recusam a usar o CPAP, também podem ser tratadas com os DAMs. A cirurgia 
ortognática de AMM é uma alternativa segura e muito eficaz de solução da SAOS.
Palavras-chave: Apneia obstrutiva do sono. Ronco. Cirurgia ortognática. Odontologia. Avanço mandibular.
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INTRODUCTION
The Obstructive Sleep Apnea and Hypopnea 
Syndrome (OSAS) is a disease that brings important 
negative impacts to people's lives. Its prevalence has 
increased worldwide1,2,3 as obesity and life expectan-
cy have multiplied. It affects about one in four men 
and one in ten women.
The diagnosis and treatment of the disease are 
often neglected, either by the lack of knowledge of 
dentists and physicians, or by non-adherence of pa-
tients to treatment. However, diagnosing and treat-
ing is of fundamental importance, and involves mul-
tiple specialties cooperating with each other or not. 
This, to a certain extent, reflects the multifactorial 
etiology of the disease,4 which have anatomical as-
pects of the airways and jaws,5 overweight,6 posture 
during sleep and other factors interacting in the es-
tablishment of OSAS.
The treatments can range from weight loss7 to max-
illomandibular advancement.8 The treatment of choice 
is influenced by the etiology of the problem, but also by 
personal yearnings — such as the desire or not to change 
the facial appearance, or the acceptance or not of sleep-
ing with a CPAP mask beside the partner — and socio-
economic characteristics of the patients.
Thus, the aim of this study was to review the lit-
erature based on the clinical experience of 25 years 
of treatment of OSAS in adults. The article mainly 
focuses on aspects of dental interest.
BASIC ASPECTS OF SLEEP PHYSIOLOGY
It has long been known that sleep is not a passive 
phenomenon. While we sleep, the Central Nervous 
System (CNS) exerts numerous activities, although 
it maintains a physiological state of loss of vigil con-
sciousness and low responsiveness to external and 
internal stimuli.
In humans, normal sleep has its own rhythm com-
posed of two distinct states — NREM (non-rapid 
eye movement) and REM (rapid eye movement) —, 
during which there is a well ordered and cyclic se-
quence of wave frequencies that are observed on 
the electroencephalogram (EEG) during the poly-
somnographic examination (Fig 1). NREM sleep, 
also called slow-wave sleep, is divided into three 
stages that follow each other as sleep consolidates, 
1, 2 and 3, the latter being called slow sleep itself, in 
which there is greater muscle hypotonia. About 90 
minutes after the onset of sleep, REM sleep or para-
doxical sleep occurs, during which there is presence 
of dreams, muscular atony and episodes of ocular 
movements. This NREM + REM sleep composi-
tion is called the sleep cycle. In a healthy adult, four 
or five sleep cycles usually occur during each night, 
with a higher concentration of stage 3 in the first 
half of the night and REM in the second.9
OSAS DEFINITION
OSAS is defined by repeated episodes, more than 
five per hour, of partial or total upper airway obstruc-
tion (UAW) during sleep, which lead to airway ob-
struction (apnea) or reduction (hypopnea) despite 
maintenance of inspiratory efforts. An apnea event, by 
definition, must last for at least 10 seconds and is usu-
ally associated with hypoxia and sleep fragmentation.9 
There is no single definition of hypopnea, but it can 
be defined as a reduction in ventilation of at least 50%, 
resulting in oxygen desaturation ≥ 4%. Blood oxygen 
desaturations are a common finding after apnea and 
hypopnea events (Fig 1).
The Apnea-Hypopnea Index (AHI), which is the 
mean number of sleep apneas and hypopneas per 
hour, determines the severity of OSAS. It is consid-
ered to be mild between 5 and 14 events, moderate 
between 15 and 29, and severe when more than 30 
episodes occur per hour of sleep.10 Other factors such 
as the oxyhemoglobin desaturation and the percent-
age of time that desaturation persists throughout 
sleep also influence the severity of OSAS.
OSAS occurs mainly during REM sleep, in 
which there is muscle atony, facilitating occlusion of 
the UAW, and most apnea events culminate with an 
awakening or microarousal that leads to the return 
of muscle tonus and cessation of UAW obstruction. 
As a consequence, it generates sleep fragmentation 
and superficialization.
The tendency of airway obstruction, or the de-
crease of its lumen, is often manifested by a noisy 
vibration of the airway, which is snoring. Most, but 
not all, patients with OSAS snore. When snoring is 
an isolated finding, with normal AHI, it can also be 
termed primary snoring or benign snoring.
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RISK FACTORS
There are many factors associated with the occurrence 
of OSAS. Anatomical changes that contribute to oropha-
ryngeal space reduction are among the most important 
of them. Thus, obese individuals with increased neck 
circumference11 and craniofacial alterations — such as in-
creased tongue base, amygdala and uvula11 — or maxil-
lomandibular deficiencies12 are at greater risk for apnea, 
because there is a reduction in the lumen of the UAW.
Sleeping in the supine position also facilitates the oc-
currence of apneas due to the posterior repositioning of 
the tongue by gravitational effect. When alcohol13 or other 
substances are ingested, such as sedatives and myorelax-
ants, this effect is made even worse by muscle relaxation at 
both the base of the tongue and the pharyngeal wall.
In addition, smoking is also a risk factor for contrib-
uting to UAW dysfunction during sleep, since it tends 
to promote relaxation of airway muscles, and due to 
neural reflexes caused by nicotine.14,15
Women in the menopausal period equate their apnea 
index with that of men, and it is believed that estrogen 
and progesterone maintain adequate muscle tone in the 
premenopausal period.16,17
DIAGNOSIS
Snoring is one of the most common predictive signs 
of OSAS, however, OSAS diagnosis is made by means 
of polysomnography (Fig 1), a test usually performed 
in a sleep laboratory. This test occurs at night while the 
patient sleeps, which allows the monitoring of various 
physiological and pathological parameters, such as apnea 
and hypopnea index, oxyhemoglobin saturation, arous-
als and microarousals, postural changes, distribution of 
stages of sleep, the electrocardiographic record and the 
intensity and frequency of snoring.17
CONSEQUENCES
The presence of untreated OSAS is associated with 
a poorer quality of life and is admittedly an independent 
risk factor for the development of various clinical dis-
eases and mental disorders.18
The cardiovascular and metabolic consequences of 
OSAS express great concern due to the high degree of le-
thality before age 65. Systemic arterial hypertension is a 
very common finding (40% to 60% of cases), and 2/3 of 
the subjects with acute myocardial infarction had moder-
ate to severe OSA. Severe OSAS increases three to four 
times the chance of developing cardiac arrhythmias and 
3.8 times the chance for stroke. In addition, it also appears 
to be an important risk factor for increased insulin resis-
tance and diabetes mellitus (types I and II).10,18
Excessive daytime sleepiness, cognitive impair-
ment, learning deficit, and mental disorders — such 
as depression and anxiety — may also be associated 
with OSAS consequences, mainly due to disruption 
of sleep cycles, which are interrupted at each apnea 
event. It is estimated that 50% of OSAS patients have 
depression as a comorbidity.10,18
Figure 1 - Segments of the polysomnographies of 
the patient presented in Figure 5, before and af-
ter orthognathic surgery. The hypnograms show 
the patient awake (W), and in the sleep stages of 
REM, 1 2 and 3. The respiratory events (apneas + 
hypopneas) are marked by vertical lines, as well 
as the microarousals (Arousals). Note that prior 
to surgery there is a certain association between 
microarousal and respiratory events. Also, blood 
oxygen saturation (SpO
2
) is associated with re-
spiratory events; the red arrow points to one of 
the desaturation events that occurred after a re-
spiratory event (blue arrow). The patient had im-
portant improvements in number of respiratory 
events, number of microarousals, blood oxygen 
saturation, and sleep quality with surgery.
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The consequences of OSAS impact on not only 
the individual, but also the society itself; there are 
indirect consequences of the disease, such as public 
expenditures, absenteeism, traffic and work acci-
dents, etc.18 After adequate OSAS treatment is ad-
ministered, all these complications have shown great 
improvement.10,18
TREATMENT
The treatment algorithm may involve weight loss, 
change of posture during sleep, but often therapies of 
varying degrees of invasiveness are indicated.
MANDIBULAR ADVANCEMENT DEVICES (MAD)
The MADs aim to maintain the mandible in an ad-
vanced position during sleep19,20 (Figs 2A, 2B; Fig 3 and 
Fig 4), promoting a transient increase of the oropharyn-
geal space during the use of the device and, consequent-
ly, reducing obstructions.21 They act by pulling the soft 
tissues anteriorly, especially the genioglossus, genius-
hyoids, digastrics and milo-hyoids muscles. The device, 
however, does not promote a correction of the airways 
that would result, in the last instance, in cure or perma-
nent improvement — its effect is observed only while 
the patient is using the device.
Ideally, the patient should be treated by the dentist 
with individualized and adjustable devices for his/her 
case. Dental arch impressions or scans are obtained for 
appliance manufacture. The device should allow a pro-
gressive adjustment of the mandibular position. Appar-
ently, less bulky appliances that cover less areas of the 
mouth are preferred by patients.22
Figure 2 - The MAD projects the mandible: A) without projection, B) with projection. Airway space volume (AS) increases (arrows) and/or an improve-
ment in pharyngeal wall tone occurs. This is due to the advancement of the tongue (T) and other para-mandibular soft tissues; even the collapse of 
the soft palate (SP) undergoes improvement. The overjet (C, in red) decreases over the years (D), by projection of the lower teeth and retraction of the 
upper ones (arrows).
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© 2019 Dental Press Journal of Orthodontics Dental Press J Orthod. 2019 May-June;24(3):99-109103
Faber J, Faber C, Faber AP special article
DC
Figure 3 - Examples of MADs: different devices can be used to adjust the mandibular position. The arrows point to screws that control the magnitude of the 
mandibular advancement and allow adjustments.
Figure 4 - Patient without (A) and with (B) an intraoral device. In this case, the patient has implant-supported dentures. The front (C) and lateral (D) views show 
the advanced mandible.
BA
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Titration of MAD
When the appliance is installed, it should keep the 
mandible in a protruded position20,23 (Fig 2B), previously 
defined in a bite record. Most people find it difficult to 
keep their mandible in a very projected position from the 
first day of treatment because they lack enough joint mo-
bility. Therefore, it is important to start using the appli-
ance gradually, increasing the time of use day by day. It is 
also important to incrementally adjust the magnitude of 
mandibular advancement, also called titration.
In the protocol adopted by the authors of the present 
article, patients are advised to begin using the device grad-
ually. Thus, they receive the recommendation to use the 
device for about only an hour in the first night, still awake. 
In the second night, they should increase the use to two 
hours. In the third, they should start sleeping with the de-
vice, but if they wake up in the middle of the night, they 
should remove it, even if they are feeling very comfortable 
with the MAD. Thus, they should advance the number of 
hours of use during sleep until the seventh day, when they 
should sleep the entire night with the device.
Similarly, the mandible should be advanced gradually 
by means of adjustments in the MAD. In the protocol 
described above, the patient initiates the treatment with 
about 4 to 5 mm of advancement. Thereafter, further ad-
vancements of 1 to 3 mm are performed per consultation 
at 3 to 5-week intervals, until a total mandibular advance-
ment of about 8 to 10 mm is achieved. Some patients toler-
ate greater advances, others never reach 8 mm.
At the end of the gradual MAD adjustment period, 
which can take from 3 to 5 months, new polysomnogra-
phy should be performed to quantify the obtained gains.
MAD side effects
There are common transitory effects. Most patients 
report sialorrhea24 at the beginning of treatment. Exces-
sive saliva flux usually decreases significantly in just over a 
month — time necessary for the brain to understand that 
the object in the mouth is not food and does not need to be 
digested. However, some patients also report dry mouth.24
In addition, patients almost always report some dis-
comfort to their teeth when they remove the device in 
the morning. This mild pain does not typically impact 
on chewing or any other function, and tends to disap-
pear still in the morning.
Part of the treated individuals report pain or oth-
er symptoms in their TMJs when using the device.25 
Pain  is most often unilateral and may be present from 
the beginning or develop years after the beginning of 
the use of the device. In the last scenario, many patients, 
can establish an association of the pain episode with 
periods of greater intensity of bruxism, often with an 
emotional trigger. 
When patients report pain, it is advisable to ask them 
to stop using the appliance for three to seven days and to 
prescribe cryotherapy on the affected joint for about ten 
minutes twice a day. This measure alone significantly 
controls pain, but the addition of nonsteroidal anti-
inflammatory drug may be recommended in the most 
significant pain conditions. Typically, we prescribe anti-
inflammatory medications for up to three days. It is in-
teresting to note that it has been observed that pain is 
more common in patients who already had pain before 
starting therapy, whereas joint sounds, clicks, and crepi-
tations may arise with time.25 
The irreversible adverse effect that occurs in practi-
cally every individual who wear a MAD for a prolonged 
period of time is tooth movement.26,27 The movements of 
the teeth tend to decrease the overjet and overbite of the 
patients (Figs 2C and 2D). This movement may even be 
positive in cases where the patient has a Class II dental rela-
tionship with excessive overbite. However, even when it is 
negative, for instance when the incisors reach an edge-to-
edge relationship or even an anterior crossbite, the MAD 
treatment can be continued. The risks that OSAS brings 
out generally outweighs any undesirable side effects in the 
dentition. However, careful monitoring needs to be done 
and the option to switch to CPAP or even MMA surgery 
should always be discussed with the patient.
When the initial negative effects on the dentition 
start, some patients choose to intercalate the MAD with a 
CPAP, to mitigate this effect. In the experience of the au-
thors of the present study, it is also common in such cases 
that patients sleep most nights with a CPAP, but travel or 
have the first nights with new partners using a MAD.
MAXILLOMANDIBULAR ADVANCEMENT SURGERY
Surgical modifications of the anatomy of the upper air-
way have been used as treatment options for patients who 
do not adhere to CPAP or MAD. There are different sur-
geries to alter soft tissues directly,28 such as laser-assisted 
uvuloplasty, radiofrequency ablation and others.29 How-
ever, the most popular soft tissue procedure is uvulopala-
topharyngoplasty (UPPP), often nicknamed triple P.
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On the other hand, soft tissue modifications can also 
be obtained by skeletal surgeries, more specifically max-
illomandibular orthognathic surgery (Figs 5 to 7).8,12,28,30
The case presented in Figure 5 is a male patient, 
39 years old, BMI = 26.3, with a major complaint of 
OSAS. The diagnostic polysomnography revealed that 
the AHI was 19.7 events/hour. Additionally, he had a 
facial asymmetry. However, he did not have any aes-
thetic complaints. The maxillomandibular advance-
ment surgery (Figs 6A and 6B) was performed with a 
mandibular advancement that exceeded the maxillary 
advancement. An counterclockwise rotation of the oc-
clusal plane was not performed, in order not to impair 
the aesthetics of the smile (Fig 7C). The planned out-
come of the surgery was obtained and led to an ante-
rior crossbite that was subsequently corrected with the 
retraction of the lower teeth with miniplates as skeletal 
anchorage (Figs 6B, 6D and 6F).
The result of the treatment was adequate from both 
aesthetical (Figs 7A to 7C) and functional perspectives. 
The treatment led to a good occlusion (Figs 7D to 7F) 
and, most importantly, a reduction of the AHI to 0.7 
events/hour.
The AHI improvement obtained in most cases28 
with the UPPP has already been shown to be inferior 
than that achieved with the MMA.31 The MMA pro-
motes changes in the airflow dynamics32 that benefits 
patients with significant reductions in AHI.
Patients undergoing MMA surgery are able to per-
ceive the positive change in the airflow immediately af-
ter surgery. They often report an easier breathing that 
they do not remember having experienced before. Typ-
ically, improvement in snoring and apnea is noticed on 
the first night, although significant swelling is already 
present, both in the airway and externally in the face.
Skeletal surgery must necessarily involve the ad-
vancement of the maxilla and the mandible. Adjunc-
tive procedures, such as cervical lipectomy, adeno-
tonsillectomy and others, may also be done during 
the same surgical procedure.33
D E F
Figure 5 - Initial photographs of patients with AHI = 19.7 who underwent surgical orthodontic treatment with the Surgery First protocol. There was a maxilloman-
dibular deficiency (A to C), in addition to a Class II malocclusion (D to F).
B CA
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Figure 7 - Final photographs of the treatment. A to C show the extraoral views: good aesthetic results were obtained. No counterclockwise rotation of the oc-
clusal plane was performed, to provide good incisor exposure when smiling (C). Good occlusion was achieved at the end of treatment (D to F).
Figure 6 - Cephalometric radiographs: initial (A) and immediately after surgery (B). Note that the mandibular advancement was greater than the maxillary 
advancement, leading to an anterior crossbite (C). This relationship was corrected by means of skeletal anchorage miniplates, which provided the necessary 
anchorage for lower arch retraction (arrows in B, D and F). The right lower first molar was removed before surgery (E). Panoramic radiographs: initial (E) and 
immediately after surgery (F).
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DISCUSSION
One component that restricts OSAS treatment is 
that treatments in general involve great patient ad-
herence. The use of a MAD or a CPAP every night 
(Fig 8) requires reasonable discipline: if a 60-year-
old English man decides to use CPAP for the rest 
of his life, which is estimated at 80.2 years,34 he 
will have to sleep with the device for 7,373 nights. 
Perhaps even more challenging is to lose weight35,36 
and maintain an adequate BMI. Thus, it is not sur-
prising that several patients discontinue treatment 
over the years, either the CPAP37 or MAD38 use or 
the maintenance of adequate BMI. Possibly, at the 
current stage of development of OSAS treatments, 
more important than finding the hypothetically op-
timal therapy for a patient, is to keep the patient in 
the treatment loop. In other words, when giving up 
one treatment option, another should be presented 
so that the patient benefits from being in treatment.
An important restriction to treatment access re-
lies in the communication with patients. The cur-
rent classification of apnea severity does not convey 
the actual severity of the disease. From the words 
used in the stratification of the disease — normal, 
mild, moderate and severe — two are suboptimal. 
In English, as in most languages, such as Portuguese 
or Italian, mild and moderate have an association 
with unimportant. Many patients with these AHI 
levels tend to underestimate the problem, and this 
can be a fatal error. It is for this reason that the au-
thors of the present paper share the opinion that 
the nomenclature should be changed to normal and 
grades I, II and III. 
The maxillomandibular advancement (MMA) 
surgery advantage is that it can be an OSAS cure for 
many individuals.8 This is not excluding the pos-
sibility that with advancing age, increased BMI, and 
changes of other natures, patients cannot have a fu-
ture worsening of AHI.
MMA beckons as a treatment option that im-
proves the AHI while promoting significant aesthetic 
and functional breathing gains32 as secondary gains. 
However, it is relatively expensive and comes with the 
inherent surgical risks. The MMA facial esthetic im-
pact influences the fact that the level of evidence on 
the association between surgery and AHI reduction is 
not very high.39 In other words, there is a limitation 
in conducting clinical trials with ideal study designs 
simply because it is very difficult to randomize indi-
viduals to a treatment alternative, such as orthognathic 
surgery, with relevant impact on patients' self-image.
Patients who are operated on need, in most cases, 
an associated orthodontic treatment. The prepa-
ration for orthognathic surgery in a conventional 
manner should only be done when a CPAP is used, 
which in a practical way rarely occurs. There is an 
urgency to perform the surgery once it is indicated, 
and unfortunately the conventional preparation for 
the surgery takes about a year and a half.40 Thus, 
patients who undergo MMA should be treated by 
means of the Surgery First protocol.41,42
MMA is often indicated for severe OSAS;43 how-
ever, patients with mild or moderate AHI can also be 
successfully treated with this procedure. Obviously, 
not everyone has an indication for MMA, and even 
within those who have, only an unknown percentage 
of patients wishes to undergo such treatment.
If MMA is a great way to treat severe OSAS, 
MADs are preferentially indicated for mild or mod-
erate OSAS.23 Patients with severe OSAS, non-ad-
herent to CPAP and who do not undergo MMA, 
may also be treated with MADs with relative suc-
cess. A significant reduction in cardiovascular mor-
tality has been observed when MADs are used in 
patients with severe OSAS.44 However, it is worth 
noting that this is not the first line of treatment for 
severe cases, but CPAP or MMA.
MADs are not devoid of limitations. Complaints 
of sialorrhea, joint and muscle pain, or simply the 
discomfort of sleeping with the device in the mouth 
Figure 8 - Photograph of a patient with severe OSAS who uses a CPAP with a 
nasal mask — the CPAP can be seen next to the bed.
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are relatively common. However, the ease of ad-
aptation increases with adequate support from the 
dentist to encourage the MAD use and to eliminate 
problems that are within the reach of the profession-
al — for example, smoothing an edge of the device 
that traumatizes the mucosa.
A very prevalent side effect when using MADs is 
tooth movement. The muscular traction that provides 
the desired effects on the pharyngeal soft tissues trig-
gers forces on the dentition. Consequently, the upper 
teeth tend to suffer a slight retraction, while the lower 
teeth protrude, resulting in decreased overjet.26 These 
changes may be positive when the patient has a Class II 
malocclusion; however, they may be undesirable in 
Class I and III cases. The decision to continue treat-
ment in cases with deleterious effects on the dentition 
relies on an analysis of each case. A switch to a CPAP 
or MMA can be considered; however, not following 
any treatment is not an appropriate option. Thus, if 
the patient is resistant to adhering to another treatment 
option, the use of MAD may be continued even if pro-
gressive changes in the occlusion still occur.
An important element in the use of MAD is that 
it is made to be used for an extended period of time, 
years on end. One should keep this in mind when 
the device is constructed. Appliances made with 
vacuum or pressure-formed plates under heat should 
be avoided. They have low durability and require 
the making of new appliances constantly.
The prevalence of OSAS is very high. A large 
portion of the world's population needs treatment 
and clinicians need to be aware of the existing treat-
ment options. When dentists do not feel able to treat 
the OSAS patient, they should screen cases and refer 
them to appropriate treatment.
CONCLUSION
OSAS is a serious health problem that has im-
portant impacts on the quality and life expectancy 
of affected individuals.
Among the risk factors for the problem are some 
of direct interest and area of  practice of the dentist, 
such as maxillomandibular deficiencies.
Some risk factors for OSAS are of direct interest 
and within the scope of dentistry, such as maxillo-
mandibular deficiencies.
MADs are a solid treatment option for primary 
snoring and mild or moderate OSAS. Patients with 
severe apnea who are non-adherent to CPAP may 
also be treated with MADs.
Maxillomandibular advancement surgery is a safe 
and very effective treatment option to OSAS.
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